Cancer Genomics Data Scientist – End-to-End Pipeline & Analysis

Natera; United States; Remote; USD 90,000 - 130,000; Full time

Benefits offered by this job

Comprehensive medical, dental, vision,

Life and disability plans

401k

Commuter benefits

Employee referral program

Job summary

Natera is seeking a Bioinformatics R&D professional to join ourCancer recurrence monitoring team. You will analyze sequencing data from large, complex cancer genomics datasets and contribute to experimental design and quality control.

You will help develop tools and end-to-end bioinformatics pipelines and work to integrate frameworks created by the R&D team. The position requires strong Python programming and hands-on NGS analysis experience, with familiarity with TCGA, COSMIC, or OncoKB.

Qualifications

• Bachelor's degree in bioinformatics, computational biology, or related field; Master's preferred.
• Minimum 2 years of hands-on high-throughput genomic sequencing analysis.
• Strong programming in Python, NGS analysis experience, and familiarity with public databases like TCGA, COSMIC, or OncoKB.

Responsibilities

• Analyze sequencing data and contribute to experimental design and quality control.
• Help develop tools and end-to-end bioinformatics pipelines.
• Integrate frameworks developed by the R&D team.

Skills

Python programming

NGS analysis

TCGA/COSMIC/OncoKB familiarity

Data QC & experimental design

Education

Bachelor's degree in bioinformatics, computational biology, or related field

Master's degree preferred

Job description

Natera is seeking a Bioinformatics R&D professional to join ourCancer recurrence monitoring team. You will analyze sequencing data from large, complex cancer genomics datasets and contribute to experimental design and quality control.

You will help develop tools and end-to-end bioinformatics pipelines and work to integrate frameworks created by the R&D team. The position requires strong Python programming and hands-on NGS analysis experience, with familiarity with TCGA, COSMIC, or OncoKB.